Envoy Medical, Inc. (COCH)

Name: Envoy Medical, Inc. (COCH) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Also trades as COCHW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001840877 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Envoy Medical, Inc. reported revenue of $241.0K. Revenue grew 7.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $207.0K.

Key ratios (year ended 2025-12-31)

-262.7%

Gross margin (computed)

n/m

Operating margin

n/m

Net margin

7.1%

Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$207.0K	$241.0K	$225.0K	$316.0K	$237.0K	n/a
Cost of Revenue	$1.00M	$874.0K	$742.0K	$789.0K	$498.0K	n/a
Gross Profit (computed)	-$798.0K	-$633.0K	-$517.0K	-$473.0K	-$261.0K	n/a
R&D Expense	$14.03M	$12.49M	$10.18M	$8.96M	$4.97M	n/a
Operating Income	-$23.62M	-$22.27M	-$19.26M	-$18.36M	-$8.71M	-$5.20M
Net Income	-$23.40M	-$23.76M	-$20.80M	-$29.92M	-$15.92M	-$251.6K
EPS (Diluted)	n/a	-$1.23	-$1.49	-$2.54	-$1.57	n/a
Total Assets	$23.95M	$8.56M	$11.54M	$8.27M	$2.56M	$426.90M
Total Liabilities	$20.25M	$20.32M	$30.38M	$10.05M	$38.75M	$38.62M
Shareholders' Equity	$3.30M	-$12.16M	-$18.84M	-$1.78M	-$36.20M	-$36.71M
Cash & Equivalents	n/a	n/a	n/a	$4.22M	$183.0K	$149.8K
Operating Cash Flow	-$21.53M	-$18.20M	-$17.95M	-$17.09M	-$8.80M	-$3.24M
Capital Expenditures	$178.0K	$179.0K	$980.0K	$153.0K	$218.0K	n/a
Free Cash Flow	-$21.71M	-$18.38M	-$18.93M	-$17.24M	-$9.02M	n/a
Dividends Paid	n/a	$1.82M	$2.45M	n/a	n/a	n/a
Shares Outstanding	n/a	n/a	n/a	19.55M	n/a	n/a
Weighted Average Diluted Shares	n/a	23.26M	18.79M	12.30M	10.12M	n/a
EPS (Basic)	n/a	-$1.23	-$1.49	-$2.54	-$1.57	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView